239 related articles for article (PubMed ID: 8614980)
1. Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures.
Schoppel K; Hassfurther E; Britt W; Ohlin M; Borrebaeck CA; Mach M
Virology; 1996 Feb; 216(1):133-45. PubMed ID: 8614980
[TBL] [Abstract][Full Text] [Related]
2. Antigenic domain 1 of human cytomegalovirus glycoprotein B induces a multitude of different antibodies which, when combined, results in incomplete virus neutralization.
Speckner A; Glykofrydes D; Ohlin M; Mach M
J Gen Virol; 1999 Aug; 80 ( Pt 8)():2183-2191. PubMed ID: 10466818
[TBL] [Abstract][Full Text] [Related]
3. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
Gromowski GD; Barrett AD
Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
[TBL] [Abstract][Full Text] [Related]
4. Identification of a variant A-specific neutralizing epitope on glycoprotein B (gB) of human herpesvirus-6 (HHV-6).
Takeda K; Okuno T; Isegawa Y; Yamanishi K
Virology; 1996 Aug; 222(1):176-83. PubMed ID: 8813034
[TBL] [Abstract][Full Text] [Related]
5. Humoral immune response to functional regions of human cytomegalovirus glycoprotein B.
Navarro D; Lennette E; Tugizov S; Pereira L
J Med Virol; 1997 Aug; 52(4):451-9. PubMed ID: 9260696
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence.
Hiramatsu K; Tadano M; Men R; Lai CJ
Virology; 1996 Oct; 224(2):437-45. PubMed ID: 8874504
[TBL] [Abstract][Full Text] [Related]
7. Clonal repertoire diversification of a neutralizing cytomegalovirus glycoprotein B-specific antibody results in variants with diverse anti-viral properties.
Barrios Y; Knör S; Lantto J; Mach M; Ohlin M
Mol Immunol; 2007 Feb; 44(5):680-90. PubMed ID: 16824601
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
Roehrig JT; Bolin RA; Kelly RG
Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
[TBL] [Abstract][Full Text] [Related]
9. Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B.
Britt WJ; Jarvis MA; Drummond DD; Mach M
J Virol; 2005 Apr; 79(7):4066-79. PubMed ID: 15767408
[TBL] [Abstract][Full Text] [Related]
10. Non-germ-line encoded residues are critical for effective antibody recognition of a poorly immunogenic neutralization epitope on glycoprotein B of human cytomegalovirus.
Lantto J; Lindroth Y; Ohlin M
Eur J Immunol; 2002 Jun; 32(6):1659-69. PubMed ID: 12115649
[TBL] [Abstract][Full Text] [Related]
11. Antigenic domains analysis of classical swine fever virus E2 glycoprotein by mutagenesis and conformation-dependent monoclonal antibodies.
Chang CY; Huang CC; Lin YJ; Deng MC; Chen HC; Tsai CH; Chang WM; Wang FI
Virus Res; 2010 May; 149(2):183-9. PubMed ID: 20132851
[TBL] [Abstract][Full Text] [Related]
12. [Conserved amino-acid residue mutations in epitope of human cytomegalovirus antigen M].
Wang B; Liu Z; Liu Y; Shen B; Liu C; Shao N
Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1128-32. PubMed ID: 18837384
[TBL] [Abstract][Full Text] [Related]
13. Syngeneic monoclonal anti-idiotype antibodies that bear the internal image of a human cytomegalovirus neutralization epitope.
Keay S; Rasmussen L; Merigan TC
J Immunol; 1988 Feb; 140(3):944-8. PubMed ID: 2448380
[TBL] [Abstract][Full Text] [Related]
14. Function of human cytomegalovirus glycoprotein B: syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies.
Tugizov S; Navarro D; Paz P; Wang Y; Qadri I; Pereira L
Virology; 1994 Jun; 201(2):263-76. PubMed ID: 8184537
[TBL] [Abstract][Full Text] [Related]
15. Autoreactivity of primary human immunoglobulins ancestral to hypermutated human antibodies that neutralize HCMV.
McLean GR; Cho CW; Schrader JW
Mol Immunol; 2006 May; 43(12):2012-22. PubMed ID: 16423397
[TBL] [Abstract][Full Text] [Related]
16. Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: its deletion leads to a strong neutralizing response.
Cleveland SM; Buratti E; Jones TD; North P; Baralle F; McLain L; McInerney T; Durrani Z; Dimmock NJ
Virology; 2000 Jan; 266(1):66-78. PubMed ID: 10612661
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains.
Li L; Barrett AD; Beasley DW
Virology; 2005 Apr; 335(1):99-105. PubMed ID: 15823609
[TBL] [Abstract][Full Text] [Related]
18. Fine mapping of neutralization epitopes on duck hepatitis B virus (DHBV) pre-S protein using monoclonal antibodies and overlapping peptides.
Chassot S; Lambert V; Kay A; Godinot C; Roux B; Trepo C; Cova L
Virology; 1993 Jan; 192(1):217-23. PubMed ID: 7685963
[TBL] [Abstract][Full Text] [Related]
19. Binding characteristics determine the neutralizing potential of antibody fragments specific for antigenic domain 2 on glycoprotein B of human cytomegalovirus.
Lantto J; Fletcher JM; Ohlin M
Virology; 2003 Jan; 305(1):201-9. PubMed ID: 12504553
[TBL] [Abstract][Full Text] [Related]
20. Characterization of complex B cell epitopes on woodchuck hepatitis virus surface antigens by using plasmids encoding chimeric proteins and DNA immunization.
Zheng X; Schirmbeck R; Hilken G; Waters JA; Yang D; Reimann J; Roggendorf M; Lu M
Virology; 2002 Mar; 294(2):342-53. PubMed ID: 12009876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
